Haosen Group was founded in 1995, and has now developed into a new pharmaceutical group integrating drug research, manufacturing, sales and pharmaceutical investment. It consists of Haosen Pharmaceutical Research Institute Co., Ltd., Shanghai Jason Pharmaceutical Chemistry Technology Co., Ltd., Lianyungang Hongchuang Pharmaceutical Co., Ltd. and Lianyungang Hengyun Pharmaceutical Technology Co., Ltd. The headquarters and manufacturing base of the group are located at the foot of beautiful Guo Huashan, in the National New Pharmaceutical Industrial Park of Lianyungang Development Zone, with clinical research and innovative drug research and development centers in Beijing and Shanghai. Haosen Pharmaceutical Co., Ltd. is a national key high-tech enterprise and one of the top 100 pharmaceutical enterprises in China. Its comprehensive competitiveness and economic benefits rank among the top in the same industry in China. The company attaches great importance to product research and development and has established a leading pharmaceutical research institute in China.